Scheibe, Madlen
Knapp, Andreas
Harst, Lorenz
Schmitt, Jochen
Funding for this research was provided by:
European Regional Development Fund and the Free State of Saxony (100278533, 100278533)
Technische Universität Dresden
Article History
Received: 12 July 2023
Accepted: 6 October 2023
First Online: 31 October 2023
Declarations
:
: Not applicable.
: Not applicable.
: MS, AK and LH declare that there is no competing interest. Unrelated to this study, JS reports institutional grants for investigator-initiated research from the German Federal Joint Committee, Federal Ministry of Health, Federal Ministry of Education and Research, European Union, Federal State of Saxony, Novartis, Sanofi, Allergologisk Laboratorium København (ALK), and Pfizer. He also participated in advisory board meetings as a paid consultant for Sanofi, Lilly, and ALK. JS serves the German Ministry of Health as a member of the Sachverständigenrat Gesundheit und Pflege (expert advisory board on health and care).